uric acid has been researched along with oxadiazoles in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertazzi, A; Bonomini, V; Mioli, V; Vangelista, A | 1 |
| Abreu, P; Gonzalez, MC; Sanchez, JJ | 1 |
| Déciga-Campos, M; López-Muñoz, FJ | 1 |
| Dai, X; Feng, Y; Gao, J; Lei, Y; Mao, Q; Wang, S; Zhang, B; Zhang, Z; Zou, Q | 1 |
| Antonopoulos, AS; Katsi, V; Michalakeas, C; Soulaidopoulos, S; Tousoulis, D; Tsioufis, K; Vlachopoulos, C | 1 |
1 review(s) available for uric acid and oxadiazoles
| Article | Year |
|---|---|
Evaluating the Safety and Tolerability of Azilsartan Medoxomil Alone or in Combination With Chlorthalidone in the Management of Hypertension: A Systematic Review.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Humans; Hypertension; Oxadiazoles; Treatment Outcome; Uric Acid | 2021 |
4 other study(ies) available for uric acid and oxadiazoles
| Article | Year |
|---|---|
[Action of propaxoline on hemodynamics and renal function in normal and pathological conditions].
Topics: Adolescent; Adult; Aged; Blood Urea Nitrogen; Creatinine; Electrolytes; Female; Hemodynamics; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Oxadiazoles; Uric Acid | 1969 |
Sodium nitroprusside stimulates L-DOPA release from striatal tissue through nitric oxide and cGMP.
Topics: Animals; Corpus Striatum; Cyclic GMP; Dose-Response Relationship, Drug; Levodopa; Male; Melatonin; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Salicylic Acid; Superoxide Dismutase; Uric Acid | 2002 |
Participation of the NO-cyclic GMP pathway in rofecoxib-induced antinociception.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Isoenzymes; Lactones; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxadiazoles; Pain; Prostaglandin-Endoperoxide Synthases; Quinoxalines; Rats; Rats, Wistar; Sulfones; Uric Acid | 2003 |
Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
Topics: Drug Design; Enzyme Inhibitors; Hyperuricemia; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Oxadiazoles; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase | 2020 |